CELLONTECH

• 2021

  • 「CartiZol」 officially launched and marketed

• 2020

  • 「CartiFill」 CSDT per AMDD (ASEAN Medical Device Directive) submitted to HAS (Health Sciences Authority) Singapore

  • ISO 13485:2016 (Quality Management System) certified

• 2019

  • National health insurance coverage for 「Chondron」 expanded, groundbreaking ceremony for ‘RMS CAMP’ and proclamation ceremony for ‘RMS Innovation 2028’ global vision held

• 2018

  • 「Chondron」 kicked off Phase 3 clinical trials in Japan, ‘Regenerative Medical System Center for Innovation’ established

• 2017

  •

  'Theraform-D' preclinical research conducted jointly with Columbia University 

  •

  Awarded the 'Research Poster' from ICOI (International Congress of Oral Implantologists) 

  •

  「RegenPatch」 gained marketing approval from the Ministry of Food and Drug Safety (MFDS) of Korea 

  •

  Selected as ‘2016 Biopharmaceutical Industrial Development Contribution Corporation’ and awarded the ‘Minister of Health and Welfare Accolade’ 

  •

  'ATELOCOLLAGEN-D.F.' registered in FDA DMF (Drug Master Files)

  • Selected as one of 52 delegation to accompany the President's visit to the White House

• 2016

  • 「CartiZol」 acquried NET (New Excellent Technology) cert.

  • 'ATELOCOLLAGEN-D.F.' registered in ICID (International Cosmetic Ingredient Dictionary and Handbook) of PCPC (The Personal Care Products Council)

• 2015

  • High concentration 「BioCollagen」 patent registered in Korea (‘High concentration collagen production method’ / Reg. No.: 10-1576060)

• 2014

  •

  「CartiFill」 received HTA (Health Technology Assessment) approval from NECA(National Evidence-based Healthcare Collaboration Agency) 

  •

  Received the Presidential award on the 42nd World Health Day (Ministry of Health and Welfare) 

  •

  ‘BioCollagen Powder’ listed in DMF (FDA) 

  •

  High concentration BioCollagen filler 「LUCIZEN」 marketing approval received from MFDS  

  
  

  • Prime Minister's Commendation received on the 28th 'Day of Medicine' (hosted by Korean Pharmaceutical Association) 

  • ISO22716 (Cosmetic GMP - Quality System Management) obtained

• 2013

  • 「CartiFill」 marketing approval received 

  • RMS Phytostem Panax Ginseng, SCE Phytostem Camellia Sinensis and SCE Phytostem Solanum Lycoperscium registered in ICID of PCPC

  • 「CartiZol」·「RegenSeal」 marketing approval obtained

• 2012

  • 「BabyCell」 approved for private cord blood banking service by Ministry of Health and Welfare

  • 「OssFill」·「SurgiFill」 marketing approval received

  • 「TheraFill」 marketing approval received in Argentina by ANMAT

  • Gel-type 「Chondron」 received HTA approval from Ministry of Health and Welfare

• 2011

  • 「TheraForm」 marketing approval

  • 「OssFill (Biomimetic Bone Supplement)」 CE MDD approval 

• 2010

  • 「TheraFill」 marketing approval received (KFDA)

• 2009

  • 「RMS Ossron」 marketing approval received

  • CE mark obtained for 「CartiFill」, 「DuoFill」, 「MRM Kit」 and 「SurgiFill」

• 2008

  • 「BioCollagen」 registered in DMF (FDA) and ICID (PCPC) 

• 2007

  •

  BioCollagen wound healing dressing 「TheraForm」 received CE approval

  • Designated as ATC (Advanced Technology Center) by Ministry of Commerce, Industry and Energy

• 2006

  • 「BioCollagen」 filler manufacturing facility construction complated (Seongsu production facility)

  • ISO13485 certification received

• 2005

  • 「RMS Ossron」 received 2005 New Technology Korea Excellence Award (Ministry of Commerce, Industry and Energy)

• 2004

  • 「Chondron」 received IR52 Jang Young Sil award and obtained KT (Excellent Korean Technology) certification

• 2003

  • 「Chondron」 awarded the silver medal from 2003 New Technology Korea

  • 「RMS Ossron」Selected as the next generational world-class product by Ministry of Commerce, Industry and Energy (2003)

• 2002

  • 「Chondron」 listed on national health insurance coverage

  • 「BabyCell」 cord blood bank service launched

• 2001

  • 「Chondron」, Autologous Chondrocyte Implantation, approved as the first bioengineering product

  • Facility KGMP certified

• 2000

  • Regenerative Medical System division and cell therapy production facility established 

• 1996

  • Tissue Engineering Research Association established